Lühmann, J.L.; Stelter, M.; Wolter, M.; Kater, J.; Lentes, J.; Bergmann, A.K.; Schieck, M.; Göhring, G.; Möricke, A.; Cario, G.;
et al. The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia. Cancers 2021, 13, 4388.
https://doi.org/10.3390/cancers13174388
AMA Style
Lühmann JL, Stelter M, Wolter M, Kater J, Lentes J, Bergmann AK, Schieck M, Göhring G, Möricke A, Cario G,
et al. The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia. Cancers. 2021; 13(17):4388.
https://doi.org/10.3390/cancers13174388
Chicago/Turabian Style
Lühmann, Jonathan Lukas, Marie Stelter, Marie Wolter, Josephine Kater, Jana Lentes, Anke Katharina Bergmann, Maximilian Schieck, Gudrun Göhring, Anja Möricke, Gunnar Cario,
and et al. 2021. "The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia" Cancers 13, no. 17: 4388.
https://doi.org/10.3390/cancers13174388
APA Style
Lühmann, J. L., Stelter, M., Wolter, M., Kater, J., Lentes, J., Bergmann, A. K., Schieck, M., Göhring, G., Möricke, A., Cario, G., Žaliová, M., Schrappe, M., Schlegelberger, B., Stanulla, M., & Steinemann, D.
(2021). The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia. Cancers, 13(17), 4388.
https://doi.org/10.3390/cancers13174388